Cochlear, founded in 1981 as a subsidiary of medical electronics company Nucleus to promote Clarke’s invention, now leads the world in this field. Over 750,000 Cochlear implants and processors ...

Superior paraolivary nucleus; VCN, Ventral cochlear nucleus; vMG, Ventral nucleus of the medial geniculate; VNLL, Ventral nucleus of the lateral lemniscus; VPA, Valproic acid.

Particularly interested in proteins that influence the wrapping of DNA around histone proteins in the nucleus of all multicellular organisms ... auditory electrophysiology; and cochlear and auditory ...

Here, we generated Task5 knock-out (KO) mice. The loss of Task5 resulted in changes in neuronal excitability in bushy cells of the ventral cochlear nucleus (VCN) and principal neurons of the medial ...

The compound action potential in the distal portion of the eighth nerve elicits wave I, while the proximal portion of the nerve, along with a contribution from the ipsilateral cochlear nucleus, ...

Melbourne’s Epiminder, which counts the $18.6 billion Cochlear as its largest shareholder, has spent six years developing its sub-scalp device to detect seizures for epilepsy patients.

This handbook contains a comprehensive collection of protocols to streamline imaging workflows and ensure reproducible ...

Local governments across China are moving to incorporate cochlear implants into their public health insurance schemes, as authorities try to reduce the cost of health care for local residents. In ...